Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Investing Cash Flow

₹3.84B

Quarterly · Period ending: · INR

RDY logo

RDY Investing Cash Flow

Latest reported₹3.84B INR
RDY Quarterly Cash from Investing · INR (-₹179.23M → ₹3.84B)
High-resolution chart · PNG

RDY investing cash flow history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Investing Cash Flow — Quarterly (INR)
Period endingInvesting Cash Flow (INR)
3,836,000,000
-28,222,427,000
-10,292,000,000
-9,543,000,000
-19,192,000,000
-13,300,000,000
-5,458,000,000
-19,071,000,000
-20,248,000,000
-142,110,940
-198,755,447
-4,517,000,000
-8,236,000,000
-15,771,000,000
-26,410,000,000
5,733,000,000
-4,923,000,000
-21,988,000,000
-2,761,000,000
3,969,000,000
-5,607,000,000
-131,938,521
43,829,950
-1,246,000,000
-15,724,000,000
-115,073,976
8,139,000,000
-1,201,000,000
-3,691,000,000
-572,000,000
-7,692,000,000
-2,925,000,000
3,462,000,000
797,000,000
-10,224,000,000
-5,229,000,000
-227,000,000
-3,240,000,000
2,061,000,000
-26,037,000,000
8,745,000,000
-5,157,000,000
-9,016,000,000
-1,614,000,000
-4,636,000,000
-14,365,000,000
-9,167,000,000
3,764,000,000
-3,136,000,000
-16,663,000,000
3,172,000,000
1,866,000,000
-4,995,000,000
-5,075,000,000
-2,345,000,000
-2,420,000,000
-4,104,000,000
-10,281,000,000
-1,382,000,000
-3,546,000,000
-3,456,000,000
-2,899,000,000
-5,572,000,000
379,000,000
-566,000,000
-3,562,000,000
-2,207,000,000
-918,000,000
-311,000,000
-953,000,000
104,508,000
261,899,000
-2,885,407,000
-2,977,230,946
-3,728,818,950
-2,470,891,084
-423,019,021
-1,461,441,274
2,647,580,264
-1,075,947,337
483,664,963
-31,604,531,632
-2,803,347,233
18,467,722
-224,260,865
816,012,494
-308,313,918
2,444,447,779
-2,319,264,292
-2,617,251,510
-2,655,508,158
-755,925,783
-491,488,394
-450,730,452
-416,243,651
-399,218,292
-682,907,340
-696,836,669
-318,482,152
-336,699,150
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.